Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neurobiol Dis ; 82: 176-184, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26093170

RESUMO

Cannabis is an increasingly popular and controversial drug used worldwide. Cannabis use often begins during adolescence, a highly susceptible period for environmental stimuli to alter functional and structural organization of the developing brain. Given that adolescence is a critical time for the emergence of mental illnesses before full-onset in early adulthood, it is particularly important to investigate how genetic insults and adolescent cannabis exposure interact to affect brain development and function. Here we show for the first time that a perturbation in disrupted in schizophrenia 1 (DISC1) exacerbates the response to adolescent exposure to delta-9-tetrahydrocannabinol (Δ(9)-THC), a major psychoactive ingredient of cannabis, consistent with the concept that gene-environment interaction may contribute to the pathophysiology of psychiatric conditions. We found that chronic adolescent treatment with Δ(9)-THC exacerbates deficits in fear-associated memory in adult mice that express a putative dominant-negative mutant of DISC1 (DN-DISC1). Synaptic expression of cannabinoid receptor 1 (CB1R) is down-regulated in the prefrontal cortex, hippocampus, and amygdala, critical brain regions for fear-associated memory, by either expression of DN-DISC1 or adolescent Δ(9)-THC treatment. Notably, elevation of c-Fos expression evoked by context-dependent fear memory retrieval is impaired in these brain regions in DN-DISC1 mice. We also found a synergistic reduction of c-Fos expression induced by cue-dependent fear memory retrieval in DN-DISC1 with adolescent Δ(9)-THC exposure. These results suggest that alteration of CB1R-mediated signaling in DN-DISC1 mice may underlie susceptibility to detrimental effects of adolescent cannabis exposure on adult behaviors.


Assuntos
Encéfalo/efeitos dos fármacos , Agonistas de Receptores de Canabinoides/farmacologia , Dronabinol/farmacologia , Emoções/efeitos dos fármacos , Interação Gene-Ambiente , Memória/efeitos dos fármacos , Proteínas do Tecido Nervoso/genética , Animais , Encéfalo/metabolismo , Modelos Animais de Doenças , Emoções/fisiologia , Medo/efeitos dos fármacos , Medo/fisiologia , Memória/fisiologia , Camundongos , Camundongos Transgênicos , Proteínas Proto-Oncogênicas c-fos/metabolismo , Receptor CB1 de Canabinoide/metabolismo
2.
World J Biol Psychiatry ; 15(1): 76-82, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24219803

RESUMO

UNLABELLED: OBJECTIVES. Disrupted in schizophrenia 1 (DISC1) is considered the most prominent candidate gene for schizophrenia. In this study, we aimed to characterize behavioural and brain biochemical traits in a mouse expressing a dominant negative DISC1mutant (DN-DISC1). METHODS: DN-DISC1 mice underwent behavioural tests to evaluate object recognition, social preference and social novelty seeking. ELISA was conducted on brain tissue to evaluate BDNF levels. Western blot was employed to measure BDNF receptor (TrkB) and cannabinoid receptor CB1. RESULTS: The mutant DISC1 mice displayed deficits in preference to social novelty while both social preference and object recognition were intact. Biochemical analysis of prefrontal cortex and hippocampus revealed a modest reduction in cortical TrkB protein levels of male mice while no differences in BDNF levels were observed. We found sex dependent differences in the expression of cannabinoid-1 receptors. CONCLUSIONS: We describe novel behavioural and biochemical abnormalities in the DN-DISC1 mouse model of schizophrenia. The data shows for the first time a possible link between DISC1 mutation and the cannabinoid system.


Assuntos
Fator Neurotrófico Derivado do Encéfalo/genética , Proteínas do Tecido Nervoso/genética , Córtex Pré-Frontal/metabolismo , Receptor CB1 de Canabinoide/genética , Esquizofrenia/genética , Comportamento Social , Animais , Modelos Animais de Doenças , Genes Dominantes/genética , Hipocampo/metabolismo , Hipocampo/patologia , Humanos , Masculino , Camundongos , Camundongos Endogâmicos CBA , Camundongos Transgênicos , Mutação , Córtex Pré-Frontal/patologia , Receptor trkB/genética , Esquizofrenia/metabolismo , Esquizofrenia/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...